Top

Published in:

Open Access 01-11-2018 | Original Research

Type 2 Diabetes in Relation to Hip Bone Density, Area, and Bone Turnover in Swedish Men and Women: A Cross-Sectional Study

Authors: Adam Mitchell, Tove Fall, Håkan Melhus, Alicja Wolk, Karl Michaëlsson, Liisa Byberg

Published in: Calcified Tissue International | Issue 5/2018

Abstract

Men and women with type 2 diabetes mellitus (T2DM) have higher risk of hip fracture, but the mechanisms are not fully understood. We aimed to investigate how T2DM, glucose, and insulin were associated with femoral bone mineral density (BMD), bone mineral area (BMA), and bone turnover markers. We used two cross-sectional cohorts: the Uppsala Longitudinal Study of Adult Men (ULSAM, n = 452, mean age 82 years) and the Swedish Mammography Cohort Clinical (SMCC, n = 4713, mean age 68 years). We identified men and women with normal fasting glucose (NFG), impaired fasting plasma glucose (IFG), and T2DM. BMD and BMA at the total hip and femoral shaft were measured using dual energy X-ray absorptiometry (DXA). Bone turnover markers; CrossLaps and osteocalcin were measured in women. Linear regression models were applied. Men and women showed a progressively higher BMD following the clinical cutoffs of fasting glucose from NFG to IFG to T2DM. In contrast, there was a progressively lower BMA. Men and women with T2DM, compared to those with NFG, had lower BMA at the total hip (− 1.7%; 95% CI − 3.2, − 0.2 and − 1.0%; 95% CI − 1.6, − 0.4) and the femoral shaft (− 2.0%; 95% CI − 3.5, − 0.4 and − 0.6%; 95% CI − 1.2, − 0.01), respectively. T2DM was associated with lower concentrations of CrossLaps (− 8.1%; 95% CI − 12.7, − 3.6) and osteocalcin (− 15.2%; 95% CI − 19.0, − 11.2). These cross-sectional results indicate that those with T2DM have smaller bone area and lower bone turnover, which could increase the risk of hip fracture.

Available only for authorised users

Fan Y, Wei F, Lang Y, Liu Y (2016) Diabetes mellitus and risk of hip fractures: a meta-analysis. Osteoporos Int 27(1):219–228. https://doi.org/10.1007/s00198-015-3279-7 CrossRefPubMed

Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1–2):136. https://doi.org/10.1007/s11657-013-0136-1 CrossRefPubMedPubMedCentral

Michaelsson K, Nordstrom P, Nordstrom A, Garmo H, Byberg L, Pedersen NL, Melhus H (2014) Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins. J Bone Miner Res 29(2):424–431. https://doi.org/10.1002/jbmr.2029 CrossRefPubMed

Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194. https://doi.org/10.1359/JBMR.050304 CrossRefPubMed

Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, Yu Q, Zillikens MC, Gao X, Rivadeneira F (2012) Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 27(5):319–332. https://doi.org/10.1007/s10654-012-9674-x CrossRefPubMedPubMedCentral

Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis. Osteoporos Int 18(4):427–444. https://doi.org/10.1007/s00198-006-0253-4 CrossRefPubMed

Karlamangla AS, Barrett-Connor E, Young J, Greendale GA (2004) Hip fracture risk assessment using composite indices of femoral neck strength: the Rancho Bernardo study. Osteoporos Int 15(1):62–70. https://doi.org/10.1007/s00198-003-1513-1 CrossRefPubMed

Ahlborg HG, Nguyen ND, Nguyen TV, Center JR, Eisman JA (2005) Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res 20(10):1820–1827. https://doi.org/10.1359/jbmr.050519 CrossRefPubMed

Seeman E, Duan Y, Fong C, Edmonds J (2001) Fracture site-specific deficits in bone size and volumetric density in men with spine or hip fractures. J Bone Miner Res 16(1):120–127. https://doi.org/10.1359/jbmr.2001.16.1.120 CrossRefPubMed

10.

Samelson EJ, Demissie S, Cupples LA, Zhang X, Xu H, Liu CT, Boyd SK, McLean RR, Broe KE, Kiel DP, Bouxsein ML (2017) Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study. J Bone Miner Res. https://doi.org/10.1002/jbmr.3240 CrossRefPubMed

11.

Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RM (2006) Features of the metabolic syndrome and the risk of nonvertebral fractures: the Tromso study. Osteoporos Int 17(3):426–432. https://doi.org/10.1007/s00198-005-0003-z CrossRefPubMed

12.

Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27(11):2231–2237. https://doi.org/10.1002/jbmr.1759 CrossRefPubMed

13.

Yano H, Ohya K, Amagasa T (1994) Effects of insulin on in vitro bone formation in fetal rat parietal bone. Endocr J 41(3):293–300CrossRefPubMed

14.

Shanbhogue VV, Finkelstein JS, Bouxsein ML, Yu EW (2016) Association between insulin resistance and bone structure in nondiabetic postmenopausal women. J Clin Endocrinol Metab 101(8):3114–3122. https://doi.org/10.1210/jc.2016-1726 CrossRefPubMedPubMedCentral

15.

Laurent MR, Cook MJ, Gielen E, Ward KA, Antonio L, Adams JE, Decallonne B, Bartfai G, Casanueva FF, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Lean MEJ, Lee DM, Pendleton N, Punab M, Claessens F, Wu FCW, Vanderschueren D, Pye SR, ONeill TW (2016) Lower bone turnover and relative bone deficits in men with metabolic syndrome: a matter of insulin sensitivity? The European Male Ageing Study. Osteoporos Int 27(11):3227–3237. https://doi.org/10.1007/s00198-016-3656-x CrossRefPubMed

16.

Calvo MS, Eyre DR, Gundberg CM (1996) Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17(4):333–368. https://doi.org/10.1210/edrv-17-4-333 CrossRefPubMed

17.

Seeman E (2003) Periosteal bone formation: a neglected determinant of bone strength. N Engl J Med 349(4):320–323. https://doi.org/10.1056/NEJMp038101 CrossRefPubMed

18.

Hygum K, Starup-Linde J, Harslof T, Vestergaard P, Langdahl BL (2017) Mechanisms in endocrinology: DIABETES mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol 176(3):R137–Rr157. https://doi.org/10.1530/eje-16-0652 CrossRefPubMed

19.

Michaelsson K, Lithell H, Vessby B, Melhus H (2003) Serum retinol levels and the risk of fracture. N Engl J Med 348(4):287–294. https://doi.org/10.1056/NEJMoa021171 CrossRefPubMed

20.

Michaelsson K, Wolk A, Byberg L, Mitchell A, Mallmin H, Melhus H (2017) The seasonal importance of serum 25-hydroxyvitamin D for bone mineral density in older women. J Intern Med 281(2):167–178. https://doi.org/10.1111/joim.12563 CrossRefPubMed

21.

Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553CrossRefPubMed

22.

Janghorbani M, Feskanich D, Willett WC, Hu F (2006) Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study. Diabetes Care 29(7):1573–1578. https://doi.org/10.2337/dc06-0440 CrossRefPubMed

23.

Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166(5):495–505. https://doi.org/10.1093/aje/kwm106 CrossRefPubMed

24.

Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR (2012) Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int 23(2):635–641. https://doi.org/10.1007/s00198-011-1595-0 CrossRefPubMed

25.

Colleluori G, Aguirre L, Dorin R, Robbins D, Blevins D, Barnouin Y, Chen R, Qualls C, Villareal DT, Armamento-Villareal R (2017) Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover. Bone 99:14–19. https://doi.org/10.1016/j.bone.2017.03.039 CrossRefPubMedPubMedCentral

26.

Cheng XG, Lowet G, Boonen S, Nicholson PH, Brys P, Nijs J, Dequeker J (1997) Assessment of the strength of proximal femur in vitro: relationship to femoral bone mineral density and femoral geometry. Bone 20(3):213–218CrossRefPubMed

27.

Kaptoge S, Dalzell N, Jakes RW, Wareham N, Day NE, Khaw KT, Beck TJ, Loveridge N, Reeve J (2003) Hip section modulus, a measure of bending resistance, is more strongly related to reported physical activity than BMD. Osteoporos Int 14(11):941–949. https://doi.org/10.1007/s00198-003-1484-2 CrossRefPubMed

28.

Black DM, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES, for the Osteoporotic Fractures in Men Research G (2008) Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J Bone Miner Res 23(8):1326–1333. https://doi.org/10.1359/JBMR.080316 CrossRefPubMedPubMedCentral

29.

Ishii S, Cauley JA, Crandall CJ, Srikanthan P, Greendale GA, Huang MH, Danielson ME, Karlamangla AS (2012) Diabetes and femoral neck strength: findings from the hip strength across the menopausal transition Study. J Clin Endocrinol Metab 97(1):190–197. https://doi.org/10.1210/jc.2011-1883 CrossRefPubMed

30.

Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Khosla S (2004) Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 19(12):1945–1954. https://doi.org/10.1359/jbmr.040916 CrossRefPubMed

31.

Garcia-Hernandez A, Arzate H, Gil-Chavarria I, Rojo R, Moreno-Fierros L (2012) High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone 50(1):276–288. https://doi.org/10.1016/j.bone.2011.10.032 CrossRefPubMed

32.

Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S (1993) Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 76(2):275–278. https://doi.org/10.1210/jcem.76.2.8432768 CrossRefPubMed

33.

Verroken C, Zmierczak HG, Goemaere S, Kaufman JM, Lapauw B (2017) Insulin resistance is associated with smaller cortical bone size in nondiabetic men at the age of peak bone mass. J Clin Endocrinol Metab 102(6):1807–1815. https://doi.org/10.1210/jc.2016-3609 CrossRefPubMed

34.

Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P (2014) Biochemical markers of bone turnover in diabetes patients—a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int 25(6):1697–1708. https://doi.org/10.1007/s00198-014-2676-7 CrossRefPubMed

35.

Carnovali M, Luzi L, Banfi G, Mariotti M (2016) Chronic hyperglycemia affects bone metabolism in adult zebrafish scale model. Endocrine 54(3):808–817. https://doi.org/10.1007/s12020-016-1106-3 CrossRefPubMed

36.

Cunha JS, Ferreira VM, Maquigussa E, Naves MA, Boim MA (2014) Effects of high glucose and high insulin concentrations on osteoblast function in vitro. Cell Tissue Res 358(1):249–256. https://doi.org/10.1007/s00441-014-1913-x CrossRefPubMed

37.

Sarkar PD, Choudhury AB (2013) Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients. Eur Rev Med Pharmacol Sci 17(12):1631–1635PubMed

38.

Tanaka K, Yamaguchi T, Kanazawa I, Sugimoto T (2015) Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells. Biochem Biophys Res Commun 461(2):193–199. https://doi.org/10.1016/j.bbrc.2015.02.091 CrossRefPubMed

39.

Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti MH, Pulvirenti I, Canzonieri E, Tringali G, Fiore CE (2012) Sclerostin levels associated with inhibition of the Wnt/beta-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab 97(10):3744–3750. https://doi.org/10.1210/jc.2012-1901 CrossRefPubMed

40.

Ardawi MS, Akhbar DH, Alshaikh A, Ahmed MM, Qari MH, Rouzi AA, Ali AY, Abdulrafee AA, Saeda MY (2013) Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone 56(2):355–362. https://doi.org/10.1016/j.bone.2013.06.029 CrossRefPubMed

41.

Manavalan JS, Cremers S, Dempster DW, Zhou H, Dworakowski E, Kode A, Kousteni S, Rubin MR (2012) Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab 97(9):3240–3250. https://doi.org/10.1210/jc.2012-1546 CrossRefPubMedPubMedCentral

42.

Hamann C, Kirschner S, Gunther KP, Hofbauer LC (2012) Bone, sweet bone–osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 8(5):297–305. https://doi.org/10.1038/nrendo.2011.233 CrossRefPubMed

43.

Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, Link TM (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(11):5045–5055. https://doi.org/10.1210/jc.2010-0226 CrossRefPubMedPubMedCentral

44.

Mazess RB, Hanson JA, Payne R, Nord R, Wilson M (2000) Axial and total-body bone densitometry using a narrow-angle fan-beam. Osteoporos Int 11(2):158–166. https://doi.org/10.1007/pl00004178 CrossRefPubMed

45.

Bazzocchi A, Ponti F, Albisinni U, Battista G, Guglielmi G (2016) DXA: technical aspects and application. Eur J Radiol 85(8):1481–1492. https://doi.org/10.1016/j.ejrad.2016.04.004 CrossRefPubMed

46.

Andersson T, Ahlbom A, Carlsson S (2015) Diabetes prevalence in Sweden at Present and projections for Year 2050. PLoS ONE 10(11):e0143084. https://doi.org/10.1371/journal.pone.0143084 CrossRefPubMedPubMedCentral

Title: Type 2 Diabetes in Relation to Hip Bone Density, Area, and Bone Turnover in Swedish Men and Women: A Cross-Sectional Study
Authors: Adam Mitchell
Tove Fall
Håkan Melhus
Alicja Wolk
Karl Michaëlsson
Liisa Byberg
Publication date: 01-11-2018
Publisher: Springer US
Published in: Calcified Tissue International / Issue 5/2018
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-018-0446-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Type 2 Diabetes in Relation to Hip Bone Density, Area, and Bone Turnover in Swedish Men and Women: A Cross-Sectional Study

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2018

Diet Quality and Bone Measurements Using HRpQCT and pQCT in Older Community-Dwelling Adults from the Hertfordshire Cohort Study

Comparison of Bone Microarchitecture Between Adult Osteogenesis Imperfecta and Early-Onset Osteoporosis

Diagnosis of Recurrent Fracture in a Pediatric Cohort

The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis

Passive Coping Strategies Are Associated With More Impairment In Quality Of Life In Patients With Fibrous Dysplasia

Deproteinization of Cortical Bone: Effects of Different Treatments

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page